RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Valerie Odero-Marah to Antineoplastic Agents

This is a "connection" page, showing publications Valerie Odero-Marah has written about Antineoplastic Agents.
Connection Strength

0.207
  1. Muniyan S, Chou YW, Ingersoll MA, Devine A, Morris M, Odero-Marah VA, Khan SA, Chaney WG, Bu XR, Lin MF. Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells. Cancer Lett. 2014 Oct 10; 353(1):59-67.
    View in: PubMed
    Score: 0.074
  2. Smith BN, Odero-Marah VA. The role of Snail in prostate cancer. Cell Adh Migr. 2012 Sep-Oct; 6(5):433-41.
    View in: PubMed
    Score: 0.065
  3. Amir S, Margaryan NV, Odero-Marah V, Khalkhali-Ellis Z, Hendrix MJ. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol Ther. 2005 Apr; 4(4):400-6.
    View in: PubMed
    Score: 0.039
  4. White EZ, Pennant NM, Carter JR, Hawsawi O, Odero-Marah V, Hinton CV. Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells. Sci Rep. 2020 07 27; 10(1):12505.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support